載入...

In MDS, is higher risk higher reward?

Patients with higher-risk myelodysplastic syndrome (HR-MDS) are defined by the original or revised International Prognostic Scoring System and specific genetic features. Treatment of HR-MDS is challenging. Allogeneic hematopoietic stem cell transplantation, the only curative approach, is feasible in...

全面介紹

Na minha lista:
書目詳細資料
發表在:Hematology Am Soc Hematol Educ Program
主要作者: Sanz, Guillermo F.
格式: Artigo
語言:Inglês
出版: American Society of Hematology 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913486/
https://ncbi.nlm.nih.gov/pubmed/31808894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000042
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!